Halobetasol Propionate Ointment
Product Images NDC 45802-131

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Halobetasol Propionate (NDC 45802-131). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Padagis Israel Pharmaceuticals Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Halobetasol-propionate-ointment.jpg (Halobetasol Propionate Ointment)

Halobetasol-propionate-ointment.jpg (Halobetasol Propionate Ointment)
This text is a description of a topical medication cream called Halobetasol Propionate Ointment, 0.05%. It contains 0.5 mg of halobetasol proionate in a base of aluminum starate, beewax, pentaerythrtol cooate, teayl iate, petoatum, popylene lycl, and sorbian sesquiolate. It's indicated for topical use only and not for use in the eyes. The usual dosage is once or twice daily or as directed by the physician. The medication should be kept out of the reach of children and stored at a controlled room temperature of 15°C-30°C (59°F-86°F). The lot number and expiration date are on the carton and crimp of the tube. The package's NDC number is 45802-131-32 E_. The text indicates that complete information is available in the insert.*
FDA Label Image

Structural Formula (Image 01)

FDA Label Image

Serialization Template

Serialization Template
This is a standard product labeling format that requires inserting the serial number, lot number, and expiration date of the product. It is used for tracking inventory and ensuring quality control.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.